Keppra XR TM Extended- Release Tablets Filed With The FDA
UCB announced that the New Drug Application (NDA) for the use of Keppra XR(TM) (levetiracetam) extended- release tablets in the adjunctive treatment of partial onset seizures in adults with epilepsy has been accepted for filing by the U.S. Food and Drug Administration (FDA).
When Mysterious Protein Deleted In Mice Deafness And Seizures Result
Scientists have discovered that mice genetically engineered to lack a particular protein in the brain have profound deafness and seizures. The finding suggests a pathway, they say, for exploring the hereditary causes of deafness and epilepsy in humans.
Epileptic Seizures In Adults Cut Using Modified Atkins Diet
A modified version of a popular high-protein, low-carbohydrate diet can significantly cut the number of seizures in adults with epilepsy, a study led by Johns Hopkins researchers suggests. The Atkins-like diet, which has shown promise for seizure control in children, may offer a new lifeline for patients when drugs and other treatments fail or cause complications.
Epilepsy Hospitalizations Rise After 8-Year Decline, USA
Epilepsy-related hospitalizations, which fell from 176, 000 in 1993 to 95, 000 in 2000, climbed to 136, 000 in 2005, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. The recent 5-year climb represented a 43 percent increase.
FDA Alerts Doctors About Suicide Risk Of Antiepileptic Drugs
The US Food and Drug Administration (FDA) issued new information, yesterday, 31st January, to alert doctors and other health professionals about the increased risk of patients having suicidal thoughts and behaviours as a result of taking antiepileptic drugs for epilepsy, bipolar disorder, migraines, and other conditions.
Cause Of Children's Seizures Pinpointed By Hypnosis
It was no way for an 11-year-old to live. For a month the boy had endured daily episodes of uncontrollable jerking and foaming at the mouth, and his physicians at Lucile Packard Children's Hospital at Stanford were concerned that the boy had epilepsy.
FDA Accepts For Review OVATION's Two NDA Submissions For Sabril R
OVATION Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the company's new drug applications (NDA) for Sabril (vigabatrin) in two types of epilepsies. The FDA assigned a priority NDA review for Sabril for the treatment of Infantile Spasms (IS), and will review the submission for refractory complex partial seizures (CPS) in the same time frame.
Researchers Find Gene Behind Rare Form Of Epilepsy, Only 3 Known Affected Individuals
Researchers have found a gene responsible for a particularly debilitating form of epilepsy that also leads to kidney failure, according to a report published online on February 28th and also in the March 7th print issue of the American Journal of Human Genetics, a publication of Cell Press.
Epilepsy Action Provides New Service For Helpline Users, UK
Advice and information about epilepsy is now available at the touch of a button thanks to a new text message service launched. Epilepsy Action, the UK's largest member-led epilepsy organisation, has introduced the new service to ensure advice and information about epilepsy is as accessible as possible.
Structure Of Brain Receptor Implicated In Epilepsy And PMT Determined By Scientists
Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have published new research in the journal Molecular Pharmacology identifying the structure of a receptor in the brain implicated in conditions such as epilepsy and pre-menstrual tension.